Zimmer Biomet Hurt by Supply Delay, Knee Challenges Remain Thu, 23 Nov 2017 14:17:02 +0000 Zimmer Biomet (ZBH) struggles with supply delay problem related to some of its products, causing inability to win back lost customers and gain new ones.
AmerisourceBergen to Take Over H. D. Smith for $815 Million Wed, 22 Nov 2017 14:14:02 +0000 AmerisourceBergen (ABC) strives to strengthen core businesses. The H. D. Smith buyout is likely to strengthen the Pharmaceutical Distribution Segment.
Rising Costs Hurt Henry Schein, End-Market Trends a Tailwind Wed, 22 Nov 2017 13:53:01 +0000 Higher cost of sales and expenses hurt Henry Schein's (HSIC) gross and operating margin. However, several end market trends like demographics are likely to benefit the company.
ImmuCell Corporation (NASDAQ/ICCC), headquartered in Portland, Maine, is engaged in the development of products used in both dairy and beef industries.
ImmuCell Announces Financial Results for Third Quarter of 2017 Mon, 13 Nov 2017 21:05:00 +0000 PORTLAND, Maine, Nov. 13, 2017-- ImmuCell Corporation, a growing animal health company that develops, manufactures and markets scientifically-proven products that improve the health and productivity of ...
ImmuCell Announces Completion of Construction of Nisin Production Facility Tue, 07 Nov 2017 11:30:00 +0000 PORTLAND, Maine, Nov. 07, 2017-- ImmuCell Corporation, a growing animal health company that develops, manufactures and markets scientifically-proven products that improve the health and productivity of ...
ImmuCell to Announce Financial Results for Third Quarter of 2017 Thu, 02 Nov 2017 15:14:32 +0000 PORTLAND, Maine, Nov. 02, 2017-- ImmuCell Corporation, a growing animal health company that develops, manufactures and markets scientifically-proven products that improve the health and productivity of ...
ImmuCell Corp. :ICCC-US: Earnings Analysis: Q2, 2017 By the Numbers : October 6, 2017 Fri, 06 Oct 2017 13:14:49 +0000 Categories: Yahoo FinanceGet free summary analysis ImmuCell Corp. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of ImmuCell Corp. – Peregrine Pharmaceuticals, Inc. (PPHM-US) that have also reported for this period. Highlights Summary numbers: Revenues of USD 1.75 million, Net Earnings of USD -0.22 million. Gross ... Read more
(Read more...)
Did ImmuCell Corporation (ICCC) Create Value For Investors Over The Past Year? Thu, 05 Oct 2017 13:16:18 +0000 ImmuCell Corporation (NASDAQ:ICCC) delivered a less impressive 2.36% ROE over the past year, compared to the 15.86% return generated by its industry. ICCC’s results could indicate a relatively inefficient operationRead More...
ImmuCell Announces Expansion of Sales and Marketing Team Wed, 13 Sep 2017 10:30:00 +0000 PORTLAND, Maine, Sept. 13, 2017-- ImmuCell Corporation, a growing animal health company that develops, manufactures and markets scientifically-proven products that improve health and productivity in the ...
Investor Network: ImmuCell Corporation to Host Earnings Call Mon, 14 Aug 2017 17:00:00 +0000 NEW YORK, NY / ACCESSWIRE / August 14, 2017 / ImmuCell Corporation (NASDAQ: ICCC) will be discussing their earnings results in their Q2 Earnings Call to be held on Monday, August 14, 2017 at 4:30 PM Eastern ...
Neogen provides products to ensure the safety of food and animals.
See what the IHS Markit Score report has to say about Neogen Corp. Wed, 22 Nov 2017 13:06:28 +0000 The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Consumer Goods sector is rising.
ETFs with exposure to Neogen Corp. : November 6, 2017 Mon, 06 Nov 2017 17:08:50 +0000 Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Neogen Corp. Here are 5 ETFs with the largest exposure to NEOG-US. Comparing the performance and risk of Neogen Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more
(Read more...)
Neogen announces science change Tue, 31 Oct 2017 13:15:00 +0000 LANSING, Mich. , Oct. 31, 2017 /PRNewswire/ -- Neogen Corporation (NASDAQ: NEOG) announced today that Dr. Daniel Kephart , formerly chief scientific officer, has resigned from the company to pursue alternative ...
Is Neogen Corporation’s (NEOG) PE Ratio A Signal To Sell For Investors? Fri, 06 Oct 2017 22:39:15 +0000 Neogen Corporation (NASDAQ:NEOG) is trading with a trailing P/E of 65.4x, which is higher than the industry average of 43.2x. While this makes NEOG appear like a stock to avoidRead More...
ETFs with exposure to Neogen Corp. : October 4, 2017 Wed, 04 Oct 2017 14:52:19 +0000 Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Neogen Corp. Here are 5 ETFs with the largest exposure to NEOG-US. Comparing the performance and risk of Neogen Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more
(Read more...)
Neogen Corp. :NEOG-US: Earnings Analysis: Q1, 2018 By the Numbers : October 3, 2017 Tue, 03 Oct 2017 13:43:59 +0000 Categories: Yahoo FinanceGet free summary analysis Neogen Corp. reports financial results for the quarter ended August 31, 2017. Highlights Summary numbers: Revenues of USD 95.26 million, Net Earnings of USD 11.91 million. Gross margins narrowed from 48.39% to 48.16% compared to the same period last year, operating (EBITDA) margins now 21.43% from 21.78%. Change in operating cash ... Read more
(Read more...)
Corporate News Blog - Neogen’s Chief Operating Officer Resigns Tue, 26 Sep 2017 11:20:00 +0000 LONDON, UK / ACCESSWIRE / September 26, 2017 / Pro-Trader Daily takes a look at the latest corporate events and news making the headlines for Neogen Corp. (NASDAQ: NEOG ), following which we have published ...
SurModics, Inc. – Value Analysis (NASDAQ:SRDX) : November 14, 2017 Tue, 14 Nov 2017 20:39:20 +0000 Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives SurModics, Inc. a score of 67. Our analysis is based on comparing SurModics, Inc. with the following peers – Nektar Therapeutics, Thermo Fisher Scientific Inc., Heron Therapeutics Inc, Abbott Laboratories, pSivida Corp., Johnson & Johnson, PerkinElmer, Inc., Enzo Biochem, Inc., Alkermes Plc and Agilent Technologies, Inc. (NKTR-US, ... Read more
(Read more...)
Surmodics Inc (SRDX): What Can We Expect In The Future? Tue, 14 Nov 2017 00:48:50 +0000 Based on the latest analyst prediction, Surmodics Inc (NASDAQ:SRDX) is estimated to immensely contract its earnings by beyond -150% next year. Presently, with an EPS of $0.298, we can expectRead More...
SurModics, Inc. breached its 50 day moving average in a Bullish Manner : SRDX-US : November 13, 2017 Mon, 13 Nov 2017 12:23:17 +0000 Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for SurModics, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bullish 50 ... Read more
(Read more...)
SurModics posts 4Q profit Wed, 08 Nov 2017 13:03:34 +0000 The Eden Prairie, Minnesota-based company said it had profit of 3 cents per share. Earnings, adjusted for non-recurring costs and amortization costs, were 18 cents per share. The drug delivery technology ...
Surmodics Reports Fourth Quarter Fiscal 2017 Results and Provides Fiscal 2018 Guidance Wed, 08 Nov 2017 12:30:00 +0000 Surmodics, Inc. , a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced results for its fiscal 2017 fourth quarter, ended September 30, 2017 and financial outlook for fiscal 2018.
SurModics, Inc. breached its 50 day moving average in a Bearish Manner : SRDX-US : November 2, 2017 Thu, 02 Nov 2017 12:30:41 +0000 Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for SurModics, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average Bullish 50 ... Read more
(Read more...)
Surmodics to Present at Canaccord Genuity Medical Technologies and Diagnostics Forum Thu, 26 Oct 2017 20:05:00 +0000 Surmodics, Inc. , a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that Gary Maharaj, president and chief executive officer, and Andy LaFrence, vice president of finance and information systems and chief financial officer, will make a presentation to the investment community at the Canaccord Genuity Medical Technologies and Diagnostics ...
ETFs with exposure to SurModics, Inc. : October 23, 2017 Mon, 23 Oct 2017 15:06:00 +0000 Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to SurModics, Inc. Here are 5 ETFs with the largest exposure to SRDX-US. Comparing the performance and risk of SurModics, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more
(Read more...)
Quidel Corporation Helping Women and Their Families Live Healthy Lives, discovers, develops, manufactures and markets point-of-care, rapid diagnostic tests for the detection of medical conditions and illnesses.
Quidel to Present at the 29th Annual Piper Jaffray Healthcare Conference Wed, 15 Nov 2017 21:05:00 +0000 Quidel Corporation , a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that it will present at the 29th Annual Piper Jaffray Healthcare Conference, to be held at the Lotte New York Palace hotel in New York, New York on Tuesday, November 28, 2017.
ETFs with exposure to Quidel Corp. : November 8, 2017 Wed, 08 Nov 2017 23:29:38 +0000 Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Quidel Corp. Here are 5 ETFs with the largest exposure to QDEL-US. Comparing the performance and risk of Quidel Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more
(Read more...)
Quidel Corp. :QDEL-US: Earnings Analysis: Q3, 2017 By the Numbers : November 7, 2017 Tue, 07 Nov 2017 13:06:02 +0000 Categories: Yahoo FinanceGet free summary analysis Quidel Corp. reports financial results for the quarter ended September 30, 2017. We analyze the earnings along side the following peers of Quidel Corp. – Bio-Rad Laboratories, Inc. Class B, OraSure Technologies, Inc., Danaher Corporation, Becton, Dickinson and Company, Thermo Fisher Scientific Inc. and PerkinElmer, Inc. (BIO.B-US, OSUR-US, DHR-US, BDX-US, TMO-US ... Read more
(Read more...)
Quidel Corp. – Value Analysis (NASDAQ:QDEL) : November 6, 2017 Mon, 06 Nov 2017 18:16:23 +0000 Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Quidel Corp. a score of 22. Our analysis is based on comparing Quidel Corp. with the following peers – Meridian Bioscience, Inc., ERBA Diagnostics, Inc., Bio-Rad Laboratories, Inc. Class B, OraSure Technologies, Inc., Danaher Corporation, Becton, Dickinson and Company, Thermo Fisher Scientific Inc. and PerkinElmer, Inc. (VIVO-US, ... Read more
(Read more...)
Quidel Corp. breached its 50 day moving average in a Bearish Manner : QDEL-US : November 3, 2017 Fri, 03 Nov 2017 12:35:53 +0000 Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Quidel Corp.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average Bullish 50 ... Read more
(Read more...)
Quidel reports 3Q loss Wed, 01 Nov 2017 22:39:58 +0000 The San Diego-based company said it had a loss of 16 cents per share. The medical diagnostics company posted revenue of $50.9 million in the period, falling short of Street forecasts. Three analysts surveyed ...
Quidel Reports Third Quarter 2017 Financial Results Wed, 01 Nov 2017 20:10:00 +0000 Quidel Corporation , a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today financial results for the third quarter ended September 30, 2017.
Quidel Receives FDA Clearance for Its Point-of-Care Sofia® Lyme FIA Mon, 23 Oct 2017 12:30:00 +0000 Quidel Corporation , a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that it has received 510 clearance from the United States Food and Drug Administration to market its Sofia Lyme FIA for the rapid differential detection of human IgM and IgG antibodies to Borrelia burgdorferi from serum and plasma specimens from patients ...
Quidel Receives FDA Clearance for Its Solana® RSV + hMPV Assay Tue, 17 Oct 2017 12:30:00 +0000 Quidel Corporation , a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that it has received clearance from the United States Food and Drug Administration to market its Solana® respiratory syncytial virus + human metapneumovirus Assay for the detection of nucleic acids isolated from nasal and nasopharyngeal swabs from patients ...
*Winners defined as our Top Picks that increased 20% or more within a 6-month period.
Red Letters imply that that particular criteria did not meet minimum requirements, e.g., a low GSA Rank would show it in red.
___ Red Line On Graph Shows a Trailing Stop Loss Based on Support and Resistance Levels. See how it works.
___ Blue Line On Graph Shows the 10-Week Moving Average.
___ Magenta Line On Graph Shows the 40-Week Moving Average.
Disclaimer The stock selections in our stock investing and stock trading database are not stock recommendations, but simply represent applications of a stock investing process. All materials, including our Top Stock Picks, are provided for information purposes only and should not be used or construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any security. Growth Stock Analytics, LLC is not responsible for gains/losses that may result in investing or trading in these securities. All information is believed to be obtained from reliable sources, but there is no guarantee that the information supplied is accurate, complete or timely. There is no guarantee or warranty with regard to the results obtained from its use. There is no guarantee of suitability or potential value of any particular investment or information source. You acknowledge that your requests for this information are unsolicited and shall neither constitute nor be considered investment advice. Past investing performance is not an indication of future performance results. Investing and trading in stocks is risky. Investors are encouraged to consult a registered stock broker or investment adviser before making any investing decisions. The interpretations and opinions expressed herein are solely those of Growth Stock Analytics, LLC, and not of any other individual or organization.
Accum/Dist: 0.81 (median winner: 1.53)
Instit. Ownership: 0% (median winner: 63%)
Disclaimer The stock selections in our stock investing and stock trading database are not stock recommendations, but simply represent applications of a stock investing process. All materials, including our Top Stock Picks, are provided for information purposes only and should not be used or construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any security. Growth Stock Analytics, LLC is not responsible for gains/losses that may result in investing or trading in these securities. All information is believed to be obtained from reliable sources, but there is no guarantee that the information supplied is accurate, complete or timely. There is no guarantee or warranty with regard to the results obtained from its use. There is no guarantee of suitability or potential value of any particular investment or information source. You acknowledge that your requests for this information are unsolicited and shall neither constitute nor be considered investment advice. Past investing performance is not an indication of future performance results. Investing and trading in stocks is risky. Investors are encouraged to consult a registered stock broker or investment adviser before making any investing decisions. The interpretations and opinions expressed herein are solely those of Growth Stock Analytics, LLC, and not of any other individual or organization.